Effect of Germicidal Ultraviolet Light (GUV) Installed in the HVAC Systems on Environmental Conditions and, Workers Health and Well Being
-
2002/05/01
-
Series: Grant Final Reports
Details
-
Personal Author:
-
Description:Microbial contamination in ventilation systems of modern office buildings has been documented to result in illness among workers. This study was conducted to test whether germicidal ultraviolet (GUV) irradiation of drip pans and cooling coils within ventilation systems of office buildings would reduce occupants work-related symptoms. A double-blind multiple crossover design was used. Within three consecutive trials, GUV was off for 12 consecutive weeks, then on for the next four weeks. In the last week with GUV off, or on, workers completed self-administered questionnaires regarding presence of symptoms and environmental satisfaction. Simultaneously, thermal, chemical and microbial parameters including endotoxin were measured outdoors, within ventilation systems and in occupied spaces. Operation of GUV lights resulted in significant reduction of microbial and endotoxin concentrations on irradiated surfaces within the ventilation systems, although airborne concentrations of these substances were unchanged. The 771 participants, who appeared to remain blinded, reported significantly fewer work-related overall (within-subject adjusted odds ratio 0.8: [95% confidence interval (0.7,0.99)], respiratory [0.6, (0.4, 0.9)] and mucosal [0.7; (0.6, 0.9)] symptoms, when the GUV were operating. Reduction of mucosal symptoms was greatest among atopic workers [0.6, (0.5, 0.8)], and neversmokers [0.7, (0.5, 0.9)]. Never-smokers also had greater reduction of respiratory [0.4, (0.2,0.9)], and musculo-skeletal symptoms [0.5 (0.3, 0.9)], with GUV on. GUV was safe, effective in reducing ventilation system surface microbial contamination as well as endotoxin, and associated with significant reduction in respirator, mucosal and overall symptoms. This effect was greater among workers at risk for allergic or hypersensitivity response to microbial antigens. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
Series:
-
Document Type:
-
Funding:
-
Genre:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:1-115
-
NIOSHTIC Number:nn:20023738
-
NTIS Accession Number:PB2004-105626
-
Citation:NIOSH 2002 May; :1-115
-
Contact Point Address:Respiratory Epidemiology Unit, McGill University, 1110 Pine Avenue West, Room 103, Montreal, QC, H3A 1A3
-
Federal Fiscal Year:2002
-
NORA Priority Area:
-
Performing Organization:McGill University, Montreal, QC
-
Peer Reviewed:False
-
Start Date:19990930
-
Source Full Name:National Institute for Occupational Safety and Health
-
End Date:20010929
-
Collection(s):
-
Main Document Checksum:urn:sha-512:122034ca5b0965967a4716cf9a1a5d0250b3dc035af3c54ed4e864f5c4d52dee497c1a963de983e7347344f5943148fbbd41324cecda120a0e33514103655c8e
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like